Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Xue

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
BMC Medicine|November 22, 2021
m<sup>6</sup>A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancerZhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
Clinical & Translational Immunology|January 11, 2021
The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non-small-cell lung cancerYuanyuan Lei, Guochao Zhang, Chaoqi Zhang, et al.
Aging|January 20, 2021
The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumorsLiyu Wang, Yu Liu, Hengchang Liu, et al.
Therapeutic Advances in Gastroenterology|March 28, 2020
Endoscopic resection techniques for squamous premalignant lesions and early carcinoma of the esophagus: ER-Cap, MBM, and ESD, how do we choose? A multicenter experienceXinying Yu, Jian Chen, Zhiqiang Yuan, et al.
Cell Host & Microbe|April 14, 2017
Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal CarcinogenesisFeng Zhu, Jami Willette-Brown, Na-Young Song, et al.
International Journal of Surgery (London, England)|October 18, 2022
A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in ChinaPeng Wu, Zhihui Zhang, Yongliang Yuan, et al.
Theranostics|September 15, 2020
Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencingLiyan Xue, Weihua Li, Xinyi Fan, et al.
Thoracic Cancer|January 8, 2025
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell CarcinomaYafan Yang, Liyan Xue, Xiankai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 TrialXin Wang, Xiaozheng Kang, Ruixiang Zhang, et al.
Cancer Innovation|April 23, 2026
Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-TumorZhe Wang, Lin Chen, Wei Rao, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
BMC Medicine|November 22, 2021
m<sup>6</sup>A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancerZhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
Clinical & Translational Immunology|January 11, 2021
The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non-small-cell lung cancerYuanyuan Lei, Guochao Zhang, Chaoqi Zhang, et al.
Aging|January 20, 2021
The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumorsLiyu Wang, Yu Liu, Hengchang Liu, et al.
Therapeutic Advances in Gastroenterology|March 28, 2020
Endoscopic resection techniques for squamous premalignant lesions and early carcinoma of the esophagus: ER-Cap, MBM, and ESD, how do we choose? A multicenter experienceXinying Yu, Jian Chen, Zhiqiang Yuan, et al.
Cell Host & Microbe|April 14, 2017
Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal CarcinogenesisFeng Zhu, Jami Willette-Brown, Na-Young Song, et al.
International Journal of Surgery (London, England)|October 18, 2022
A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in ChinaPeng Wu, Zhihui Zhang, Yongliang Yuan, et al.
Theranostics|September 15, 2020
Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencingLiyan Xue, Weihua Li, Xinyi Fan, et al.
Thoracic Cancer|January 8, 2025
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell CarcinomaYafan Yang, Liyan Xue, Xiankai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 TrialXin Wang, Xiaozheng Kang, Ruixiang Zhang, et al.
Cancer Innovation|April 23, 2026
Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-TumorZhe Wang, Lin Chen, Wei Rao, et al.
Pageof 18